€148.80
0.81% today
Xetra, Aug 12, 09:06 am CET
ISIN
DE000A2YNT30
Symbol
ACT
Index
Sector
Industry

Alzchem Group Stock price

€147.60
+0.80 0.55% 1M
+83.71 131.01% 6M
+91.40 162.62% YTD
+97.31 193.51% 1Y
+130.01 739.32% 3Y
+129.89 733.29% 5Y
+65.13 78.98% 10Y
+110.29 295.57% 20Y
Xetra, Closing price Mon, Aug 11 2025
-1.60 1.07%
ISIN
DE000A2YNT30
Symbol
ACT
Index
Sector
Industry

Key metrics

Basic
Market capitalization
€1.5b
Enterprise Value
€1.5b
Net debt
positive
Cash
€64.3m
Shares outstanding
10.1m
Valuation (TTM | estimate)
P/E
25.8 | 25.6
P/S
2.7 | 2.6
EV/Sales
2.7 | 2.5
EV/FCF
51.9
P/B
7.0
Dividends
DPS
€1.80
Yield 1Y | 5Y
1.2% | 5.0%
Growth 1Y | 5Y
50.0% | 19.1%
Payout 1Y | 3Y
33.9% | 34.7%
Increased
6 Years
Financials (TTM | estimate)
Revenue
€555.5m | €585.4m
EBITDA
€111.6m | €115.1m
EBIT
€85.2m | €86.8m
Net Income
€57.9m | -
Free Cash Flow
€28.9m
Growth (TTM | estimate)
Revenue
1.0% | 5.6%
EBITDA
14.2% | 8.2%
EBIT
19.3% | 8.4%
Net Income
25.0% | -
Free Cash Flow
-54.6%
Margin (TTM | estimate)
Gross
65.7%
EBITDA
20.1% | 19.7%
EBIT
15.3%
Net
10.4% | -
Free Cash Flow
5.2%
Financial Health
Equity Ratio
42.5%
Return on Equity
26.3%
ROCE
19.0%
ROIC
15.7%
Debt/Equity
0.2
More
EPS
€5.7
FCF per Share
€2.9
Short interest
-
Employees
2k
Rev per Employee
€340.0k
Show more

Is Alzchem Group a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,025 stocks worldwide.

Alzchem Group Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a Alzchem Group forecast:

9x Buy
82%
2x Hold
18%

Analyst Opinions

11 Analysts have issued a Alzchem Group forecast:

Buy
82%
Hold
18%

Financial data from Alzchem Group

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
556 556
1% 1%
100%
- Direct Costs 190 190
6% 6%
34%
365 365
5% 5%
66%
- Selling and Administrative Expenses 183 183
16% 16%
33%
- Research and Development Expense - -
-
-
112 112
14% 14%
20%
- Depreciation and Amortization 26 26
0% 0%
5%
EBIT (Operating Income) EBIT 85 85
19% 19%
15%
Net Profit 58 58
25% 25%
10%

In millions EUR.

Don't miss a Thing! We will send you all news about Alzchem Group directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

AlzChem Group AG engages in the development, production, and marketing of chemical products. It operates through the following segments: Specialty Chemicals, Basics and Intermediates, and Other and Holding. The Specialty Chemicals segment focuses on the production and distribution of growth products that contain specialty chemicals such as CreAMINO, Creapure, BioSelect, Silzot, DYHARD, and Dormex. The Basics & Intermediates segment covers the production of basic and intermediate products. The Other & Holding segment comprises of services to the chemical parks in Trostberg and Hart. The company was founded on October 10, 1984 is headquartered in Trostberg, Germany.

Head office Germany
CEO Andreas Niedermaier
Employees 1,647
Founded 1984
Website www.alzchem.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today